Anúncio
Anúncio

MNMD

MNMD logo

Mind Medicine (MindMed) Inc. Common Shares

14.03
USD
Patrocinado
+0.52
+3.82%
07 de jan., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

13.86

-0.17
-1.18%

Relatórios de Lucros MNMD

Rácio de surpresa positiva

MNMD separação 10 de 20 últimas estimativas.

50%

Próximo Relatório

Data do Próximo Relatório
04 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.52
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
-33.33%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
+26.83%

Mind Medicine (MindMed) Inc. Common Shares earnings per share and revenue

On 06 de nov. de 2025, MNMD reported earnings of -0.78 USD per share (EPS) for Q3 25, missing the estimate of -0.51 USD, resulting in a -52.55% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +3.17% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analistas forecast an EPS of -0.52 USD, with revenue projected to reach -- USD, implying an diminuir of -33.33% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, Mind Medicine (MindMed) Inc. Common Shares reported EPS of -$0.78, missing estimates by -52.55%, and revenue of $0.00, 0% as expectations.
The stock price moved up 3.17%, changed from $11.34 before the earnings release to $11.70 the day after.
The next earning report is scheduled for 04 de mar. de 2026.
Based on 14 analistas, Mind Medicine (MindMed) Inc. Common Shares is expected to report EPS of -$0.52 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio